Contract Pharmaceutical Manufacturing, Research and Packaging

Home
Medical Equipment and Supplies
Pharmaceuticals
Contract Pharmaceutical Manufacturing, Research and Packaging

Contract Pharmaceutical Manufacturing, Research and Packaging

Price:

USD $4,850.00

ISBN/SKU #:

GB-PHM043C

Research Group:

BCC

Date of Publication:

October 2009

Summary

The goal in conducting this study is to provide an overview of the current and future characteristics of the global market for contract manufacturing, research, and packaging in the pharmaceuticals industry. The key objective is to present a comprehensive analysis of the current market and its future direction in the pharmaceuticals and biotechnology outsourcing industry with the emphasis on contract manufacturing.

This report explores present and future strategies within the contract manufacturing, research, and packaging pharmaceuticals industry. The needs, services offered, criteria for selection, and the advantages of outsourcing are discussed. The study also includes the need for project management, market forecasts and a discussion of the market leaders in the industry. Regulatory requirements and current state of the outsourcing market in the pharmaceuticals and biotechnology industry are also portrayed in this report.

A detailed analysis of the pharmaceutical-biopharmaceutical contract manufacturing, research, and packaging industry structure has been conducted. Revenues are broken down by bulk as well as by dosage forms of solid, liquid, and semisolid pharmaceuticals. Sales figures are estimated for the 5 year period from 2009 through 2014.

Over-the-counter (OTC), nutritional, and drug-delivery products are discussed separately in this report. Contract research and contract packaging are also discussed separately. Many pharmaceutical companies choose outsourcing as an option, or choice, to better market their products without spending time in drug discovery and the manufacturing process. These pharmaceutical companies rely on contract manufacturers and researchers. This study examines the different types of contracting companies in the pharmaceuticals industry. Rapid development of technologies and major changes in market behavior also justify a focus on this segment.

Several important trends in outsourcing need to be tracked and analyzed. Outsourcing in the pharmaceuticals industry has changed in recent years. The major reason behind the use of contract-manufacturing organizations (CMOs) in the pharmaceuticals industry is the innovative and state-of-the-art process and production technologies CMOs offer. Other reasons to contract an outsourced company are to achieve efficiencies in cost, capacity, time-to-market, and the need to obtain specific expertise not available in-house.

This study contributes to the areas of market growth in pharmaceuticals contract manufacturing, research, and packaging from the point of view of manufacturers and users. Biochemical companies, physicians, the pharmaceuticals and biopharmaceuticals industries, and pharmaceutical research companies will find value in this study.

The scope of this study encompasses the contract manufacturing, research, and packaging markets. The report analyzes each market and its applications by its need for outsourcing, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.

THIS REPORT:

Offers a thorough review of the global market for contract manufacturing, research and packaging in the pharmaceutical business
Provides the current global market status for contract manufacturing, research, and packaging and forecasts for growth through 2014
Discusses the advantages and disadvantages of outsourcing
Covers technological issues including the latest trends and developments
Describes the regulatory environment.

TABLE OF CONTENTS

Chapter- 1: INTRODUCTION -- Complimentary

STUDY OBJECTIVES

REASONS FOR DOING THIS STUDY

INTENDED AUDIENCE

SCOPE OF THE STUDY

METHODOLOGY

INFORMATION SOURCES

ABOUT THE AUTHOR

RELATED BCC RESEARCH REPORTS

BCC ONLINE SERVICES

DISCLAIMER

Chapter-2: SUMMARY

SUMMARY

SUMMARY TABLE WORLDWIDE PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, THROUGH 2014 ($ BILLIONS)

SUMMARY FIGURE WORLDWIDE PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, 2007-2014 ($ BILLIONS)

Chapter-3: OVERVIEW

DEFINITIONS

CONTRACT MANUFACTURING

CONTRACT MANUFACTURER

TYPES OF CONTRACT MANUFACTURERS

CORE COMPETENCIES

VENDOR

CONTRACT RESEARCH ORGANIZATION (CRO)

HISTORY OF OUTSOURCING

Chapter-4: CONTRACT MANUFACTURING

NEED FOR CONTRACT MANUFACTURING

FLEXIBILITY

CAPACITY AND CAPITAL

RISK

ADVANTAGES OF CONTRACT MANUFACTURING

TABLE 1 KEY ADVANTAGES OF CONTRACT MANUFACTURING

SELECTION OF CONTRACT MANUFACTURER

MISCONCEPTIONS REGARDING CONTRACT MANUFACTURERS

Chapter-5: CONTRACT RESEARCH

INCLUDED IN RESEARCH

DRUG DISCOVERY AND DEVELOPMENT

CLINICAL RESEARCH

ANALYTICAL RESEARCH

NEED FOR CONTRACT RESEARCH

SERVICES OFFERED BY CONTRACT RESEARCH ORGANIZATION

SELECTION AND MANAGEMENT OF CRO

Chapter-6: CONTRACT PACKAGING

CONTRACT PACKAGING

THE NEED FOR CONTRACT PACKAGING

CRITERIA FOR THE SELECTION OF A PACKAGING SERVICE

LOCATION

EXPERIENCE

PERSONALITY

FINANCIAL STRENGTH

ADVANTAGES OF CONTRACT PACKAGING

Chapter-7: THE NEED FOR PROJECT MANAGEMENT

PROJECT EVALUATION AND SET UP

PLANNING AND EXECUTION

QUALITY MANAGEMENT

MANAGEMENT OF QUALITY COMPONENTS FROM CLIENT’S PERSPECTIVE

MANAGEMENT OF QUALITY COMPONENTS FROM THE CMO PERSPECTIVE

Chapter-8: REGULATORY ASPECTS

SHORT SUPPLY ARRANGEMENTS

DIVIDED MANUFACTURING ARRANGEMENTS

SHARED MANUFACTURING ARRANGEMENTS

RESPONSIBILITIES OF EACH PARTICIPATING MANUFACTURER

CONTRACT MANUFACTURING ARRANGEMENTS

RESPONSIBILITIES OF LICENSED MANUFACTURER

TABLE 2 RESPONSIBILITIES OF LICENSED MANUFACTURER UNDER FDA ACTS

RESPONSIBILITIES OF THE CONTRACT MANUFACTURER

WARNING LETTERS

WARNING LETTERS ISSUED TO CONTRACT MANUFACTURERS

APPROVALS OF MANUFACTURING FACILITIES

Chapter-9: INDUSTRY STRUCTURE

MARKET SHARES OF INDUSTRY LEADERS

CONTRACT MANUFACTURERS OF BULK DRUGS AND APIS

TABLE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2009 (%)

FIGURE 1 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/API, 2009 (%)

CONTRACT MANUFACTURERS OF SOLID DOSAGE FORMS

TABLE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2009 (%)

FIGURE 2 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2009 (%)

CONTRACT MANUFACTURERS OF LIQUID DOSAGE FORMS

NONSTERILE

TABLE 5 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2009 (%)

FIGURE 3 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING NON-STERILE LIQUID DOSAGE FORMS, 2009 (%)

STERILE

TABLE 6 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2009 (%)

FIGURE 4 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING STERILE LIQUID DOSAGE FORMS, 2009 (%)

CONTRACT MANUFACTURERS OF SEMISOLID DOSAGE FORMS

TABLE 7 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2009 (%)

FIGURE 5 WORLDWIDE MARKET SHARES OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2009 (%)

CONTRACT RESEARCH COMPANIES

TABLE 8 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2009 (%)

FIGURE 6 WORLDWIDE MARKET SHARES OF CONTRACT RESEARCH COMPANIES, 2009 (%)

CONTRACT PACKAGING COMPANIES

TABLE 9 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2009 (%)

FIGURE 7 WORLDWIDE MARKET SHARES OF CONTRACT PACKAGING COMPANIES, 2009 (%)

TYPES OF CONTRACT MANUFACTURING AND RESEARCH FIRMS

TABLE 10 SERVICES PROVIDED BY CONTRACT MANUFACTURING AND RESEARCH FIRMS

TABLE 11 SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS BY PACKAGING TYPE

Chapter-10: TECHNOLOGY TRANSFER

REASONS FOR TECHNOLOGY TRANSFER

CHALLENGING PROBLEMS DURING TECHNOLOGY TRANSFER

PRELIMINARY STEPS TOWARD TECHNOLOGY TRANSFER

STEPS FOR SUCCESSFUL TECHNOLOGY TRANSFER

TYPES OF CONTRACTUAL AGREEMENTS USED IN TECHNOLOGY TRANSFER

CONFIDENTIAL DISCLOSURE AGREEMENT (CDA)

MATERIAL TRANSFER AGREEMENT (MTA)

ASSIGNMENT DEED

LICENSE AGREEMENT

CO-DEVELOPMENT AND CO-MARKETING AGREEMENTS

FACTORS FOR A SUCCESSFUL PROJECT

Chapter-11: NEW DEVELOPMENTS

QUINTILES INC.

COVANCE

CHARLES RIVER LABORATORIES

OTHERS

Chapter-12: MARKETS

CONTRACT MANUFACTURING

CONTRACT MANUFACTURE OF BULK DRUGS/APIS

Market Overview

Market Revenue

TABLE 12 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)

FIGURE 8 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)

Market Shares

TABLE 13 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)

FIGURE 9 WORLDWIDE BULK DRUG/API CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)

CONTRACT MANUFACTURE OF ORAL DOSAGE FORMULATIONS

Solid Dosage Formulations

Market Overview

Market Revenue

TABLE 14 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)

FIGURE 10 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)

Market Shares

TABLE 15 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)

FIGURE 11 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)

Market by Formulation

Market Revenue

TABLE 16 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ BILLIONS)

FIGURE 12 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ BILLIONS)

TABLE 17 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)

FIGURE 13 WORLDWIDE SOLID DOSAGE FORM CONTRACT MANUFACTURING, MARKET SHARES BY FORMULATION, 2009 (%)

Liquid Dosage Formulations

Market Overview

Non-sterile Formulations

Market Revenue

TABLE 18 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)

FIGURE 14 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)

Market Shares

TABLE 19 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2006 (%)

FIGURE 15 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)

Sterile Formulations

Market Revenue

TABLE 20 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)

FIGURE 16 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)

Market Shares

TABLE 21 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)

FIGURE 17 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)

Market by Formulation

Non-sterile Formulations

TABLE 22 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)

FIGURE 18 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ MILLIONS)

TABLE 23 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)

FIGURE 19 WORLDWIDE LIQUID DOSAGE FORM (NON-STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)

Sterile Formulations

TABLE 24 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)

FIGURE 20 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING REVENUE BY FORMULATION, 2007-2014 ($ MILLIONS)

TABLE 25 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)

FIGURE 21 WORLDWIDE LIQUID DOSAGE FORM (STERILE) CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)

CONTRACT MANUFACTURE OF SEMISOLID DOSAGE FORMULATIONS

Market Overview

Market Revenue

TABLE 26 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)

FIGURE 22 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)

Market Shares

TABLE 27 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)

FIGURE 23 WORLDWIDE SEMI-SOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)

Market by Formulation

TABLE 28 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)

FIGURE 24 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING REVENUE BY FORMULATION, THROUGH 2014 ($ MILLIONS)

TABLE 29 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)

FIGURE 25 WORLDWIDE SEMISOLID DOSAGE FORM CONTRACT MANUFACTURING MARKET SHARES BY FORMULATION, 2009 (%)

CONTRACT MANUFACTURE OF ADVANCED DRUG DELIVERY PRODUCTS

Market Overview

TABLE 30 CONTRACTING COMPANIES PROVIDING DRUG DELIVERY SYSTEMS

Market Revenue

TABLE 31 WORLDWIDE CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)

FIGURE 26 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)

Market Shares

TABLE 32 WORLDWIDE DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)

FIGURE 27 WORLDWIDE DRUG DELIVERY CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)

Market by Formulation

TABLE 33 WORLDWIDE CONTRACTING COMPANIES PROVIDING ADVANCED DRUG DELIVERY SYSTEMS REVENUE BY TYPE, THROUGH 2014 ($ BILLIONS)

FIGURE 28 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2007-2014 ($ BILLIONS)

Market Shares

TABLE 34 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING SHARE BY TYPE, 2009 (%)

FIGURE 29 WORLDWIDE ADVANCED DRUG DELIVERY SYSTEM CONTRACT MANUFACTURING REVENUE BY TYPE, 2009 (%)

CONTRACT MANUFACTURE OF OTC AND NUTRITIONAL PRODUCTS

Market Overview

Market Revenue

TABLE 35 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)

FIGURE 30 WORLDWIDE OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)

Market Shares

TABLE 36 WORLDWIDE OTC AND NUTRITIONAL PRODUCTS CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)

FIGURE 31 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY REGION, 2009 (%)

Market by Formulation

TABLE 37 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY DOSAGE FORM, THROUGH 2014 ($ BILLIONS)

FIGURE 32 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING REVENUE BY DOSAGE FORM, 2007-2014 ($ BILLIONS)

TABLE 38 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2009 (%)

FIGURE 33 WORLDWIDE OTC AND NUTRITIONAL PRODUCT CONTRACT MANUFACTURING MARKET SHARES BY DOSAGE FORM, 2009 (%)

CONTRACT RESEARCH

MARKET OVERVIEW

Partnerships

Expansions of Facilities

MARKET REVENUE

TABLE 39 WORLDWIDE CONTRACT PHARMACEUTICAL RESEARCH MARKET BY REGION, THROUGH 2014 ($ BILLIONS)

FIGURE 34 WORLDWIDE CONTRACT PHARMACEUTICAL RESEARCH MARKET BY REGION, 2007-2014 ($ BILLIONS)

MARKET SHARES

TABLE 40 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY REGION, 2009 (%)

FIGURE 35 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY REGION, 2009 (%)

MARKET BY DISCIPLINE

TABLE 41 WORLDWIDE CONTRACT RESEARCH REVENUE BY DISCIPLINE, THROUGH 2014 ($ BILLIONS)

FIGURE 36 WORLDWIDE CONTRACT RESEARCH REVENUE BY DISCIPLINE, 2007-2014 ($ BILLIONS)

MARKET SHARES BY DISCIPLINE

TABLE 42 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2009 (%)

FIGURE 37 WORLDWIDE CONTRACT RESEARCH MARKET SHARES BY DISCIPLINE, 2009 (%)

CONTRACT PACKAGING

MARKET OVERVIEW

MARKET REVENUE

TABLE 43 WORLDWIDE CONTRACT PACKAGING MARKET BY REGION, THROUGH 2014 ($ BILLIONS)

FIGURE 38 WORLDWIDE CONTRACT PACKAGING MARKET BY REGION, 2007-2014 ($ BILLIONS)

MARKET SHARES

TABLE 44 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY REGION, 2009 (%)

FIGURE 39 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY REGION, 2009 (%)

MARKET BY PACKAGE TYPE

MARKET REVENUE

TABLE 45 WORLDWIDE CONTRACT PACKAGING MARKET BY PACKAGE TYPE, THROUGH 2014 ($ BILLIONS)

FIGURE 40 WORLDWIDE CONTRACT PACKAGING MARKET BY PACKAGE TYPE, 2007-2014 ($ BILLIONS)

MARKET SHARES

TABLE 46 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2009 (%)

FIGURE 41 WORLDWIDE CONTRACT PACKAGING MARKET SHARES BY PACKAGE TYPE, 2009 (%)

Chapter-13: CONTRACT MANUFACTURING APPLICATIONS

CARDIOVASCULAR DRUG MARKET

MARKET REVENUE

TABLE 47 WORLDWIDE REVENUE FROM CONTRACT MANUFACTURE OF CARDIOVASCULAR DRUGS BY REGION, THROUGH 2014 ($ MILLIONS)

FIGURE 42 WORLDWIDE CARDIOVASCULAR DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)

REPRODUCTIVE DRUG MARKET

MARKET REVENUE

TABLE 48 WORLDWIDE REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)

FIGURE 43 WORLDWIDE REPRODUCTIVE DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)

ONCOLOGY DRUG MARKET

MARKET REVENUE

TABLE 49 WORLDWIDE ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)

FIGURE 44 WORLDWIDE ONCOLOGY DRUG AND DIAGNOSTIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)

ANALGESIC MARKET

MARKET REVENUE

TABLE 50 WORLDWIDE ANALGESIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)

FIGURE 45 WORLDWIDE ANALGESIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)

ANTIVIRAL DRUGS MARKET

MARKET REVENUE

TABLE 51 WORLDWIDE ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)

FIGURE 46 WORLDWIDE ANTIVIRAL DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)

ANTIBIOTICS MARKET

MARKET REVENUE

TABLE 52 WORLDWIDE ANTIBIOTIC CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ MILLIONS)

FIGURE 47 WORLDWIDE ANTIBIOTIC CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ MILLIONS)

MARKETS FOR OTHER DRUGS

MARKET REVENUE

TABLE 53 WORLDWIDE OTHER DRUG CONTRACT MANUFACTURING REVENUE BY REGION, THROUGH 2014 ($ BILLIONS)

FIGURE 48 WORLDWIDE OTHER DRUG CONTRACT MANUFACTURING REVENUE BY REGION, 2007-2014 ($ BILLIONS)

Chapter-14: PATENT ANALYSIS

PATENTS BY YEAR

TABLE 54 NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2005-2009

FIGURE 49 NUMBER OF PATENTS BY YEAR, 2005-2009

FIGURE 50 NUMBER OF PATENTS BY YEAR, 2005–2009 (%)

PATENTS BY COMPANY

TABLE 55 NUMBER OF U.S. PATENTS BY COMPANY, 2005-2009

PATENTS BY COUNTRY

TABLE 56 NUMBER OF U.S. PATENTS BY COUNTRY, 2005-2009

TABLE 57 PATENT SHARES BY COUNTRY, 2005-2009 (%)

FIGURE 51 PATENT SHARES BY COUNTRY, 2005-2009 (%)

PATENTS BY EMPHASIS

TABLE 58 PATENTS BY EMPHASIS, 2005-2009

Chapter-15: CURRENT ENVIRONMENT

OVERALL SITUATION OF THE CONTRACTING MARKET

CONTRACT MANUFACTURING OF API AND DOSAGE FORMS

CONTRACT MANUFACTURING OF OTC AND NUTRACEUTICALS

CONTRACT RESEARCH

CONTRACT PACKAGING

SUCCESS FACTORS FOR CMOS

PRESENT SCENARIO OF THE CONTRACT MANUFACTURING MARKET

FROM THE PHARMACEUTICAL COMPANIES’ PERSPECTIVE

FROM CONTRACT MANUFACTURING ORGANIZATION’S PERSPECTIVE

FACTORS AFFECTING THE OUTSOURCING MARKET

COST CONTAINMENT

GLOBALIZATION

MERGERS AND ACQUISITIONS

REGULATORY REQUIREMENTS

NEED FOR SPECIALIZED SERVICES

COMPETITION WITHIN THE PHARMACEUTICAL INDUSTRY

INTRODUCTION OF NEW BIOTHERAPEUTICS

Chapter-16: COMPANY PROFILES

AAI PHARMA, INC.

ABBOTT LABORATORIES

AEROGEN, INC.

ALBANY MOLECULAR RESEARCH, INC.

ALCAN PACKAGING

ALKERMES, INC.

AMERISOURCE BERGEN

A. P. PHARMA, INC.

ARADIGM CORPORATION

BAXTER HEALTHCARE

BEN VENUE LABORATORIES INC.

BIOVAIL CORP.

BOEHRINGER INGELHEIM

BOOTS MANUFACTURING

CAMBREX CORP.

CANGENE

CATALENT PHARMA SOLUTIONS

CEDARBURG HAUSER PHARMACEUTICAL LTD.

CENEXI

CHARLES RIVER LABORATORIES

CHEMBRIDGE CORP.

CONFAB LABORATORIES

COVANCE INC.

DAVOS PHARMA

DECODE GENETICS

DIOSYNTH BIOTECHNOLOGY

DISHMAN PHARMACEUTICALS AND CHEMICALS LTD.

DOW CHEMICAL COMPANY

DPT LABORATORIES INC.

DR REDDY’S LABORATORIES

DSM PHARMACEUTICAL PRODUCTS

ELAN DRUG TECHNOLOGIES

EVOTEC AG

FULCRUM PHARMA PLC

GENZYME PHARMACEUTICALS

GIRINDUS AG

GLAXOSMITHKLINE BIOPHARMACEUTICALS

HOVIONE S.A.

JUBILANT ORGANOSYS

KENDLE INTERNATIONAL INC.

KING PHARMACEUTICALS

KP PHARMACEUTICAL TECHNOLOGIES INC

K.V. PHARMACEUTICAL CO.

LIGAND PHARMACEUTICALS

LONZA GROUP

LYNE LABORATORIES

MALLINCKRODT

MDS PHARMA SERVICES

MEDAREX INC.

MIKART INC

NORWICH PHARMACEUTICALS

NOVAVAX, INC.

OMNICARE CLINICAL RESEARCH

PAREXEL INTERNATIONAL CORPORATION

PATHEON INC.

PERRIGO COMPANY

PHARMACEUTICAL PRODUCT DEVELOPMENT INC.

PIRAMAL HEALTHCARE

PRA INTERNATIONAL

QUINTILES

RANBAXY RESEARCH LABS

REGIS TECHNOLOGIES, INC.

SCHWARZ PHARMA AG

SKYEPHARMA

TALECRIS BIOTHERAPEUTICS INC.

WUXI APP TEC

XCELLEREX, LLC

APPENDIX : ABBREVIATIONS

APPENDIX

Warranty Information

Number of Pages: 187

New Publications